Midas Pharma
From EverybodyWiki Bios & Wiki
Midas Pharma is a German pharmaceutical company founded in 1988.[1] The company has 300 employees (as of 2023) and revenue of 550 million EUR (2023). Among other products,[2] it makes a biosimilar for ranibizumab under brand name Ranivisio, approved in 2022 by EMA.[3]
References
- ↑ "History". www.midas-pharma.com. Retrieved 2024-09-04.
- ↑ "Midas Pharma - discover our products". www.midas-pharma.com. Retrieved 2024-09-04.
- ↑ "Ranivisio Authorization details". EMA.
External links
 | This German corporation or company article is a stub. You can help EverybodyWiki by expanding it. |
This article "Midas Pharma" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Midas Pharma. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
